BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8837732)

  • 1. Isolation of lipophosphoglycans from Leishmania donovani amastigotes.
    McNeely TB; Doyle PS
    Arch Biochem Biophys; 1996 Oct; 334(1):1-8. PubMed ID: 8837732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions.
    Mahoney AB; Sacks DL; Saraiva E; Modi G; Turco SJ
    Biochemistry; 1999 Aug; 38(31):9813-23. PubMed ID: 10433687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the glucosyltransferases that assemble the side chains of the Indian Leishmania donovani lipophosphoglycan.
    Mahoney AB; Turco SJ
    Arch Biochem Biophys; 1999 Dec; 372(2):367-74. PubMed ID: 10600177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids.
    McConville MJ; Blackwell JM
    J Biol Chem; 1991 Aug; 266(23):15170-9. PubMed ID: 1831200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fatty acid and monosaccharide compositions of three neutral and three phosphorylated glycolipids isolated from Leishmania donovani promastigotes grown in a chemically defined medium.
    Wyder MA; Sul D; Kaneshiro ES
    J Parasitol; 1999 Oct; 85(5):771-8. PubMed ID: 10577709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a stage-specific lipophosphoglycan in Leishmania major amastigotes.
    Turco SJ; Sacks DL
    Mol Biochem Parasitol; 1991 Mar; 45(1):91-9. PubMed ID: 1646960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.
    Saar Y; Ransford A; Waldman E; Mazareb S; Amin-Spector S; Plumblee J; Turco SJ; Zilberstein D
    Mol Biochem Parasitol; 1998 Sep; 95(1):9-20. PubMed ID: 9763285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophosphoglycan-like glycoconjugate of Tritrichomonas foetus and Trichomonas vaginalis.
    Singh BN
    Mol Biochem Parasitol; 1993 Feb; 57(2):281-94. PubMed ID: 8433719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell function.
    Ho JL; Kim HK; Sass PM; He S; Geng J; Xu H; Zhu B; Turco SJ; Lo SK
    J Immunol; 1996 Oct; 157(7):3013-20. PubMed ID: 8816410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of lipophosphoglycan (LPG) and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture.
    Mukhopadhyay S; Sen P; Majumder HK; Roy S
    J Parasitol; 1998 Jun; 84(3):644-7. PubMed ID: 9645879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycan.
    Frankenburg S; Leibovici V; Mansbach N; Turco SJ; Rosen G
    J Immunol; 1990 Dec; 145(12):4284-9. PubMed ID: 2147940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics.
    Debrabant A; Joshi MB; Pimenta PF; Dwyer DM
    Int J Parasitol; 2004 Feb; 34(2):205-17. PubMed ID: 15037106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental regulation of proline transport in Leishmania donovani.
    Mazareb S; Fu ZY; Zilberstein D
    Exp Parasitol; 1999 Apr; 91(4):341-8. PubMed ID: 10092478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis of lipophosphoglycan from Leishmania donovani: characterization of mannosylphosphate transfer in vitro.
    Carver MA; Turco SJ
    Arch Biochem Biophys; 1992 Jun; 295(2):309-17. PubMed ID: 1586160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a ricin-resistant mutant of Leishmania donovani that expresses lipophosphoglycan.
    Phillips MR; Turco SJ
    Glycobiology; 2015 Apr; 25(4):428-37. PubMed ID: 25472443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.
    Lodge R; Diallo TO; Descoteaux A
    Cell Microbiol; 2006 Dec; 8(12):1922-31. PubMed ID: 16848789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania.
    Lodge R; Descoteaux A
    Clin Immunol; 2005 Mar; 114(3):256-65. PubMed ID: 15721836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and partial characterization of a lipophosphoglycan from a pathogenic strain of Entamoeba histolytica.
    Bhattacharya A; Prasad R; Sacks DL
    Mol Biochem Parasitol; 1992 Nov; 56(1):161-8. PubMed ID: 1474994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation.
    Pescher P; Blisnick T; Bastin P; Späth GF
    Cell Microbiol; 2011 Jul; 13(7):978-91. PubMed ID: 21501362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmentally regulated changes in the cell surface architecture of Leishmania parasites.
    McConville MJ; Ralton JE
    Behring Inst Mitt; 1997 Mar; (99):34-43. PubMed ID: 9303200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.